These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15517533)

  • 1. Adverse reactions of Topiramate and Lamotrigine in children.
    Shechter T; Shorer Z; Kramer U; Lerman-Sagie T; Ronen E; Rotem R; Gorodischer R
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):187-92. PubMed ID: 15517533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer anticonvulsants: lamotrigine, topiramate and gabapentin.
    Holmes LB; Hernandez-Diaz S
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):599-606. PubMed ID: 22730257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
    Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
    Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate.
    Gerber PE; Hamiwka L; Connolly MB; Farrell K
    Pediatr Neurol; 2000 Mar; 22(3):200-3. PubMed ID: 10734250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios.
    Lathers CM; Schraeder PL; Claycamp HG
    J Clin Pharmacol; 2003 May; 43(5):491-503. PubMed ID: 12751270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin, lamotrigine, topiramate and serum carnitine levels.
    Zelnik N; Isler N; Goez H; Shiffer M; David M; Shahar E
    Pediatr Neurol; 2008 Jul; 39(1):18-21. PubMed ID: 18555168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P; Singh S; Goyal V; Shukla G; Behari M
    Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
    Knudsen JF; Sokol GH; Flowers CM
    J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience.
    Mohamed K; Appleton R; Rosenbloom L
    Seizure; 2000 Mar; 9(2):137-41. PubMed ID: 10845739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of side effects on long-term retention in three new antiepileptic drugs.
    Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
    Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric postmarketing pharmacovigilance using prescription-event monitoring: comparison of the adverse event profiles of lamotrigine prescribed to children and adults in England.
    Aurich-Barrera B; Wilton L; Brown D; Shakir S
    Drug Saf; 2010 Sep; 33(9):751-63. PubMed ID: 20701408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.